List of Publications Prof. Dr. Andreas Kirschning
Showing results 41 - 50 out of 321
2020
Harms, V., Kirschning, A., & Dickschat, J. S. (2020). Nature-driven approaches to non-natural terpene analogues. Natural Product Reports, 37(8), 1080-1097. https://doi.org/10.1039/c9np00055k
Elgaher, W. A. M., Hamed, M. M., Baumann, S., Herrmann, J., Siebenbürger, L., Krull, J., Cirnski, K., Kirschning, A., Brönstrup, M., Müller, R., & Hartmann, R. W. (2020). Cystobactamid 507: Concise synthesis, mode of action, and optimization toward more potent antibiotics. Chemistry - A European Journal, 26(32), 7219-7225. https://doi.org/10.1002/chem.202000117
Nawasreh, M., Kirschning, A., Duddeck, H., Dräger, G., & Fenske, D. (2020). Novel double functional protection of cephalostatin analogues using a gas-free chlorination method. Heliyon, 6(1), Article e03025. Advance online publication. https://doi.org/10.1016/j.heliyon.2019.e03025, https://doi.org/10.15488/10867
2019
Geist, E., Berneaud-Kötz, H., Baikstis, T., Dräger, G., & Kirschning, A. (2019). Toward Chromanes by de Novo Construction of the Benzene Ring. Organic Letters, 21(22), 8930-8933. Advance online publication. https://doi.org/10.1021/acs.orglett.9b03209
Warnecke, A., Kirschning, A., Zeilinger, C., & Landsberg, D. (2019). Hsp90: A target for susceptibilities and substitutions in biotechnological and medicinal application. In A. A. A. Asea, & P. Kaur (Eds.), Heat Shock Protein 90 in Human Diseases and Disorders (1. ed., pp. 387-410). (Heat Shock Proteins (HESP); Vol. 19). Springer. https://doi.org/10.1007/978-3-030-23158-3_18
Moeller, M., Norris, M. D., Planke, T., Cirnski, K., Herrmann, J., Müller, R., & Kirschning, A. (2019). Scalable Syntheses of Methoxyaspartate and Preparation of the Antibiotic Cystobactamid 861-2 and Highly Potent Derivatives. Organic Letters, 21(20), 8369-8372. Advance online publication. https://doi.org/10.1021/acs.orglett.9b03143
Kirschning, A., Friese, C., & Coutable, L. (2019). processo para a produção de ésteres de ácido cianoacrílico na presença de catalisadores de metais de transição. (Patent No. BR112012000467). https://worldwide.espacenet.com/patent/search/family/042575758/publication/BR112012000467A2?q=BR112012000467A2
Hermane, J., Eichner, S., Mancuso, L., Schröder, B., Sasse, F., Zeilinger, C., & Kirschning, A. (2019). New geldanamycin derivatives with anti Hsp properties by mutasynthesis. Organic and Biomolecular Chemistry, 17(21), 5269-5278. https://doi.org/10.1039/c9ob00892f, https://doi.org/10.15488/10458
Banda, D. H., Perin, P. M., Brown, R. J. P., Todt, D., Solodenko, W., Hoffmeyer, P., Kumar Sahu, K., Houghton, M., Meuleman, P., Müller, R., Kirschning, A., & Pietschmann, T. (2019). A central hydrophobic E1 region controls the pH range of hepatitis C virus membrane fusion and susceptibility to fusion inhibitors. Journal of Hepatology, 70(6), 1082-1092. Advance online publication. https://doi.org/10.1016/j.jhep.2019.01.033
Planke, T., Moreno, M., Hüttel, S., Fohrer, J., Gille, F., Norris, M. D., Siebke, M., Wang, L., Müller, R., & Kirschning, A. (2019). Cystobactamids 920‑1 and 920-2: Assignment of the Constitution and Relative Configuration by Total Synthesis. Organic Letters, 21(5), 1359-1363. Advance online publication. https://doi.org/10.1021/acs.orglett.9b00058
